SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001104659-20-117347
Filing Date
2020-10-22
Accepted
2020-10-22 21:57:50
Documents
8
Effectiveness Date
2020-10-22

Document Format Files

Seq Description Document Type Size
1 FORM S-3MEF tm2033321-2_fwp.htm S-3MEF 53894
2 EXHIBIT 5.1 tm2033321d2_ex5-1.htm EX-5.1 14473
3 EXHIBIT 5.2 tm2033321d2_ex5-2.htm EX-5.2 15445
4 EXHIBIT 23.1 tm2033321d2_ex23-1.htm EX-23.1 3248
5 GRAPHIC tm2033321d2_ex5-1img01.jpg GRAPHIC 8994
6 GRAPHIC tm2033321d2_ex5-1img02.jpg GRAPHIC 1918
7 GRAPHIC tm2033321d2_ex5-2img01.jpg GRAPHIC 4342
8 GRAPHIC tm2033321d2_ex23-1img001.jpg GRAPHIC 2915
  Complete submission text file 0001104659-20-117347.txt   113834
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-249623 | Film No.: 201255929
SIC: 2834 Pharmaceutical Preparations